MedTrace Logo

Evaluating the Implementation and Impact of Navigator-delivered ePRO System

NCT04809740 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3090

Last updated 2026-06-16

Study results available
· View outcomes & findings →

Summary

Evaluate implementation of navigator-delivered Home ePRO for all cancer patients across multiple practice sites and assess the impact of Home ePRO on clinical and utilization outcomes.

Conditions

Interventions

OTHER

Navigator-delivered Home ePRO

The intervention includes standard of care weekly symptom survey delivery to patients, with alerts generated for symptoms that are sent to clinic nurses to address per standard of care protocol

Sponsors & Collaborators

  • University of South Alabama

    collaborator OTHER

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • University of Alabama at Birmingham

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-04
Primary Completion
2025-12-31
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04809740 on ClinicalTrials.gov